Literature DB >> 34234837

Corrigendum to "Effects of Nonpharmacological Interventions on Balance Function in Patients with Osteoporosis or Osteopenia: A Network Meta-Analysis of Randomized Controlled Trials".

Lu Zhu1, Wenzhong Wu1, Ming Chen1, Daoming Xu1, Huaning Xu1, Lanying Liu1, Jing Liu1, Zequan Zhu1.   

Abstract

[This corrects the article DOI: 10.1155/2021/6662510.].
Copyright © 2021 Lu Zhu et al.

Entities:  

Year:  2021        PMID： 34234837      PMCID： PMC8216816          DOI： 10.1155/2021/9892786

Source DB:  PubMed          Journal:  Evid Based Complement Alternat Med        ISSN： 1741-427X            Impact factor:   2.629


In the article titled “Effects of Nonpharmacological Interventions on Balance Function in Patients with Osteoporosis or Osteopenia: A Network Meta-Analysis of Randomized Controlled Trials” [1], the Acknowledgments section was omitted. The corrected section is given as follows.
  1 in total

1.  Effects of Nonpharmacological Interventions on Balance Function in Patients with Osteoporosis or Osteopenia: A Network Meta-Analysis of Randomized Controlled Trials.

Authors:  Lu Zhu; Wenzhong Wu; Ming Chen; Daoming Xu; Huaning Xu; Lanying Liu; Jing Liu; Zequan Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-04       Impact factor: 2.629
  1 in total
  2 in total

1.  The Effects of Er Xian Decoction Combined with Baduanjin Exercise on Bone Mineral Density, Lower Limb Balance Function, and Mental Health in Women with Postmenopausal Osteoporosis: A Randomized Controlled Trial.

Authors:  Keqiang Li; Hongli Yu; Xiaojun Lin; Yuying Su; Lifeng Gao; Minjia Song; Hongying Fan; Daniel Krokosz; Huixin Yang; Mariusz Lipowski
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-30       Impact factor: 2.650

2.  Analysis of Influencing Factors of Medication Compliance in Patients with Recurrent Vertebral Fractures after Percutaneous Kyphoplasty and the Role of Family-Centered Education Intervention.

Authors:  Jinglin Li; Minqin Gu; Yingqing Jiang
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-22       Impact factor: 2.629
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.